Literature DB >> 23688691

Neurologic manifestations of chronic methamphetamine abuse.

Daniel E Rusyniak1.   

Abstract

The drug with perhaps the greatest impact on the practice of Psychiatry is Methamphetamine. By increasing the extracellular concentrations of dopamine while slowly damaging the dopaminergic neurotransmission, Meth is a powerfully addictive drug whose chronic use preferentially causes psychiatric complications. Chronic Meth users have deficits in memory and executive functioning as well as higher rates of anxiety, depression, and most notably psychosis. It is because of addiction and chronic psychosis from Meth abuse that the Meth user is most likely to come to the attention of the practicing Psychiatrist/Psychologist. Understanding the chronic neurologic manifestations of Meth abuse will better arm practitioners with the diagnostic and therapeutic tools needed to make the Meth epidemic one of historical interest only.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23688691      PMCID: PMC3764482          DOI: 10.1016/j.psc.2013.02.005

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  102 in total

1.  COMPARISON OF AMPHETAMINE PSYCHOSIS AND SCHIZOPHRENIA.

Authors:  D S BELL
Journal:  Br J Psychiatry       Date:  1965-08       Impact factor: 9.319

2.  For the dental patient ... methamphetamine use and oral health.

Authors: 
Journal:  J Am Dent Assoc       Date:  2005-10       Impact factor: 3.634

Review 3.  Amphetamine-induced movement disorder.

Authors:  Michael A Downes; Ian M Whyte
Journal:  Emerg Med Australas       Date:  2005-06       Impact factor: 2.151

4.  Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity.

Authors:  Jannine G Truong; Diana G Wilkins; Jakub Baudys; Dennis J Crouch; Kamisha L Johnson-Davis; James W Gibb; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2005-05-18       Impact factor: 4.030

5.  Methamphetamine abuse and emergency department utilization.

Authors:  J R Richards; S W Bretz; E B Johnson; S D Turnipseed; B T Brofeldt; R W Derlet
Journal:  West J Med       Date:  1999-04

6.  Choreoathetoid movements in cocaine dependence.

Authors:  G Bartzokis; M Beckson; D A Wirshing; P H Lu; J A Foster; J Mintz
Journal:  Biol Psychiatry       Date:  1999-06-15       Impact factor: 13.382

7.  Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis.

Authors:  Chih-Ken Chen; Shih-Ku Lin; Pak C Sham; David Ball; El-Wui Loh; Robin M Murray
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-07-05       Impact factor: 3.568

Review 8.  Implications of chronic methamphetamine use: a literature review.

Authors:  Charles W Meredith; Craig Jaffe; Kathleen Ang-Lee; Andrew J Saxon
Journal:  Harv Rev Psychiatry       Date:  2005 May-Jun       Impact factor: 3.732

Review 9.  Cerebrovascular and cardiovascular complications of alcohol and sympathomimetic drug abuse.

Authors:  Ayrn D O'Connor; Daniel E Rusyniak; Askiel Bruno
Journal:  Med Clin North Am       Date:  2005-11       Impact factor: 5.456

Review 10.  Dystonia and chorea in acquired systemic disorders.

Authors:  J L Janavs; M J Aminoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

View more
  37 in total

Review 1.  Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways.

Authors:  Irina N Krasnova; Zuzana Justinova; Jean Lud Cadet
Journal:  Psychopharmacology (Berl)       Date:  2016-02-12       Impact factor: 4.530

2.  Acute Parkinsonism and Basal Ganglia Damage from Crystal Methamphetamine.

Authors:  Wissam Deeb; Justin Yancey; Irene Malaty
Journal:  Mov Disord Clin Pract       Date:  2016-11-16

Review 3.  Non-coding RNA: insights into the mechanism of methamphetamine neurotoxicity.

Authors:  Ying-Jian Gu; Lei Chen; Lin Cheng; Ming-Yuan Zhou; Yun Wang
Journal:  Mol Cell Biochem       Date:  2021-04-25       Impact factor: 3.396

4.  The Neuroprotective Effect of L-Stepholidine on Methamphetamine-Induced Memory Deficits in Mice.

Authors:  Mei Zhou; Xiaokang Gong; Qin Ru; Qi Xiong; Lin Chen; Yuanren Si; Huaqiao Xiao; Chaoying Li
Journal:  Neurotox Res       Date:  2019-06-14       Impact factor: 3.911

5.  Effect of three different regimens of repeated methamphetamine on rats' cognitive performance.

Authors:  Seyedeh Masoumeh Seyedhosseini Tamijani; Elmira Beirami; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Cogn Process       Date:  2017-09-25

6.  Neurochemical and behavioral comparisons of contingent and non-contingent methamphetamine exposure following binge or yoked long-access self-administration paradigms.

Authors:  Catherine A Schweppe; Caitlin Burzynski; Subramaniam Jayanthi; Bruce Ladenheim; Jean Lud Cadet; Eliot L Gardner; Zheng-Xiong Xi; Henriette van Praag; Amy Hauck Newman; Thomas M Keck
Journal:  Psychopharmacology (Berl)       Date:  2020-05-09       Impact factor: 4.530

7.  Clinical characteristics and outcomes of methamphetamine-associated intracerebral hemorrhage.

Authors:  Dionne E Swor; Matthew B Maas; Sandeep S Walia; David P Bissig; Eric M Liotta; Andrew M Naidech; Kwan L Ng
Journal:  Neurology       Date:  2019-05-29       Impact factor: 9.910

8.  Androgen-primed castrate males are sufficient for methamphetamine-facilitated increases in proceptive behavior in female rats.

Authors:  Sarah A Rudzinskas; Jessica A Mong
Journal:  Horm Behav       Date:  2015-10-20       Impact factor: 3.587

9.  Compulsive methamphetamine taking under punishment is associated with greater cue-induced drug seeking in rats.

Authors:  Oscar V Torres; Subramanian Jayanthi; Bruce Ladenheim; Michael T McCoy; Irina N Krasnova; Jean Lud Cadet
Journal:  Behav Brain Res       Date:  2017-03-09       Impact factor: 3.332

10.  Sex differences in impulsivity and brain morphometry in methamphetamine users.

Authors:  Shannon Kogachi; Linda Chang; Daniel Alicata; Eric Cunningham; Thomas Ernst
Journal:  Brain Struct Funct       Date:  2016-04-19       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.